Portfolio company
pathway-dx
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company provides biomarker development and laboratory testing services to pharmaceutical firms for drug development programs.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Lanterne Dx
This company provides histopathology and biomarker validation services to pharmaceutical and biotechnology organisations to support drug development and clinical research.
Meadowhawk Biolabs
This company provides preclinical research services, including bioanalysis and pharmacology studies, to biotechnology and pharmaceutical firms to support drug discovery and development.
LiquidCell Dx
This company develops blood-based liquid biopsy tests for tumor microenvironment profiling to help pharmaceutical companies and clinical partners predict cancer therapy responses.
Olink Proteomics
This company develops protein biomarker analysis platforms and immunoassay panels for pharmaceutical firms and academic researchers to support drug discovery and disease research.
ACS Biomarker
This company provides biomarker discovery and validation services for cardiovascular disease diagnostics to academic research groups and pharmaceutical industry partners.
Metabolon
This company develops metabolomics profiling kits and analysis services for pharmaceutical, biotechnology, and academic researchers to identify biomarkers and understand biological pathways.
PathAI
This company provides artificial intelligence software for pathology to support biopharmaceutical firms and clinical laboratories with drug development and diagnostic analysis.
Pathology
This company provides anatomic and molecular diagnostic testing services to healthcare providers, specializing in women's health and oncology.
